BBB

Responding to the Urgent Need for Blood, a San Diego Blood Drive Will be Held on February 27th 9:00am to 2:30pm at Better Business Bureau, 4747 Viewridge Ave., San Diego

Retrieved on: 
Friday, February 16, 2024

SAN DIEGO, Feb. 16, 2024 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units. Anyone considering donating blood can visit SanDiegoBloodBank.org or call 619-400-8251. Appointments are encouraged, but walk-ins are welcome.

Key Points: 
  • To meet the needs of local patients the San Diego Blood Bank must collect more than 350 units of blood each day.
  • SAN DIEGO, Feb. 16, 2024 /PRNewswire-PRWeb/ -- The life-saving work of the San Diego Blood Bank serves hospitals in Southern California, including trauma centers and neonatal intensive care units.
  • "We are grateful for the opportunity to positively impact our community by partnering with the San Diego Blood Bank to support this donation drive."
  • We're proud to support the life-saving donation drive and partner with fantastic organizations like the San Diego Blood Bank, "says Milad Hassibi, marketing manager, Mulligan Funding.

Fairfax India Holdings Corporation: Financial Results for the Year Ended December 31, 2023

Retrieved on: 
Thursday, February 15, 2024

TORONTO, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Fairfax India Holdings Corporation (TSX: FIH.U) announces fiscal year 2023 net earnings of $371.8 million ($2.72 net earnings per diluted share), compared to 2022 net earnings of $191.4 million ($1.34 net earnings per diluted share). The company's book value per share at December 31, 2023 of $21.85 increased compared to $20.89 at September 30, 2023 ($19.11 at December 31, 2022) through the realization of gains on the sales of investments and strong performance of the investment portfolio. The company's book value per share has grown at a compound annual growth rate of 9.2% (9.6% prior to the performance fee described below) from the initial public offering price of $10.00 per share. The company's growth in 2023 was supported by strong Indian equity markets and economic fundamentals.

Key Points: 
  • The financial results are derived from financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS®"), except as otherwise noted, and are unaudited.
  • See "Glossary of non-GAAP and other financial measures" at the end of this press release for further details.)
  • Fairfax India is in strong financial health, with cash and marketable securities at December 31, 2023 of approximately $209 million, prior to the sales of NSE described below.
  • Particularly, statements regarding future results, performance, achievements, prospects or opportunities of the company, an Indian Investment, or the Indian market are forward-looking statements.

Elite Roofing Release New Article on the Different Roof Types Available in Los Angeles to Help Homeowners and Businesses Choose the Best Roof Material

Retrieved on: 
Thursday, February 15, 2024

Elite Roofing, a premier roofing company specialising in commercial and residential roof installation, replacement, and roof repair in los angeles , is proud to announce the release of its new article on the different roof types available in Los Angeles to help local homeowners and businesses choose the best roof material to suit their specific needs.

Key Points: 
  • Elite Roofing, a premier roofing company specialising in commercial and residential roof installation, replacement, and roof repair in los angeles , is proud to announce the release of its new article on the different roof types available in Los Angeles to help local homeowners and businesses choose the best roof material to suit their specific needs.
  • The BBB-rated A+ company hopes its article will help demystify the different roof types available and empower its local community to select the best roof to match their budget, lifestyle, and unique specifications.
  • Shingle Roof: One of the most popular styles for residential roofing in Los Angeles, shingle roofing is characterized by attractive, flat, rectangular elements that overlap.
  • If you’re searching for “ Roofing company near me ” or roof repair in Los Angeles, look no further than Elite Roofing.

Securitas AB upgraded to 'BBB' by S&P Global Ratings

Retrieved on: 
Wednesday, February 14, 2024

STOCKHOLM, Feb. 14, 2024 /PRNewswire/ -- Securitas AB was today upgraded to `BBB' with stable outlook.

Key Points: 
  • STOCKHOLM, Feb. 14, 2024 /PRNewswire/ -- Securitas AB was today upgraded to `BBB' with stable outlook.
  • Based on lower leverage and strong cash flow generation, S&P's Global Ratings has upgraded its long-term credit rating on Securitas to BBB from BBB-.
  • The outlook is stable.
  • The following files are available for download:

Securitas AB upgraded to 'BBB' by S&P Global Ratings

Retrieved on: 
Wednesday, February 14, 2024

STOCKHOLM, Feb. 14, 2024 /PRNewswire/ -- Securitas AB was today upgraded to `BBB' with stable outlook.

Key Points: 
  • STOCKHOLM, Feb. 14, 2024 /PRNewswire/ -- Securitas AB was today upgraded to `BBB' with stable outlook.
  • Based on lower leverage and strong cash flow generation, S&P's Global Ratings has upgraded its long-term credit rating on Securitas to BBB from BBB-.
  • The outlook is stable.
  • The following files are available for download:

JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders

Retrieved on: 
Wednesday, February 14, 2024

JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced the presentation of several datasets demonstrating the potential benefits of its investigational therapies for lysosomal storage disorders (LSDs).

Key Points: 
  • JCR Pharmaceuticals Co., Ltd. (TSE 4552; Chairman and President: Shin Ashida; “JCR”) today announced the presentation of several datasets demonstrating the potential benefits of its investigational therapies for lysosomal storage disorders (LSDs).
  • JCR is dedicated to address the unmet medical needs for this community,” said Shin Ashida, President and CEO of JCR Pharmaceuticals.
  • Finally, the third JR-141 presentation is pre-clinical and highlights the recovery of retinal function in mice with MPS II.
  • “We are pleased to be able to offer IZCARGO® to patients with MPS II in Japan,” said Yoshikatsu Eto, M.D., Ph.D., Institute of Neurological Disorders, Advanced Clinical Research Center, Kanagawa, Japan.

KBRA Assigns and Publishes Ratings for AG Twin Brook Capital Income Fund

Retrieved on: 
Tuesday, February 13, 2024

KBRA publishes and assigns issuer and senior unsecured debt ratings of BBB for AG Twin Brook Capital Income Fund ("TCAP" or "the company").

Key Points: 
  • KBRA publishes and assigns issuer and senior unsecured debt ratings of BBB for AG Twin Brook Capital Income Fund ("TCAP" or "the company").
  • On January 30, 2024, these ratings were assigned on an unpublished basis.
  • TPG Angelo Gordon provides the company with robust deal sourcing, a strong sponsor network, and extensive banking relationships.
  • Additional information regarding KBRA policies, methodologies, rating scales and disclosures are available at www.kbra.com.

BBB Industries announces strategic leadership changes

Retrieved on: 
Monday, February 12, 2024

DAPHNE, Ala., Feb. 12, 2024 /PRNewswire/ -- BBB Industries, LLC (BBB), a leading sustainable manufacturer serving the automotive and industrial markets, announced two strategic leadership changes today. 

Key Points: 
  • DAPHNE, Ala., Feb. 12, 2024 /PRNewswire/ -- BBB Industries, LLC (BBB) , a leading sustainable manufacturer serving the automotive and industrial markets, announced two strategic leadership changes today.
  • Boyer has been with BBB since 2015 and has served in various roles, most recently serving as President of TERREPOWER , BBB's innovative solar system and EV battery lifecycle management division.
  • Maria Caballero is appointed President of TERREPOWER, a division of BBB Industries.
  • These key changes within our senior leadership team reflect our relentless pursuit of innovation, growth, and competitive excellence," said Duncan Gillis, Chief Executive Officer of BBB.

BBB Industries announces strategic leadership changes

Retrieved on: 
Monday, February 12, 2024

DAPHNE, Ala., Feb. 12, 2024 /PRNewswire/ -- BBB Industries, LLC (BBB), a leading sustainable manufacturer serving the automotive and industrial markets, announced two strategic leadership changes today.

Key Points: 
  • DAPHNE, Ala., Feb. 12, 2024 /PRNewswire/ -- BBB Industries, LLC (BBB) , a leading sustainable manufacturer serving the automotive and industrial markets, announced two strategic leadership changes today.
  • Boyer has been with BBB since 2015 and has served in various roles, most recently serving as President of TERREPOWER , BBB's innovative solar system and EV battery lifecycle management division.
  • Maria Caballero is appointed President of TERREPOWER, a division of BBB Industries.
  • These key changes within our senior leadership team reflect our relentless pursuit of innovation, growth, and competitive excellence," said Duncan Gillis, Chief Executive Officer of BBB.

Elkem: Fourth quarter 2023 concludes a challenging year, signs of recovery

Retrieved on: 
Thursday, February 8, 2024

Elkem's total operating income for the fourth quarter 2023 was NOK 8,436 million, which was up 7% from the third quarter 2023, explained by improved performance in the Silicones division.

Key Points: 
  • Elkem's total operating income for the fourth quarter 2023 was NOK 8,436 million, which was up 7% from the third quarter 2023, explained by improved performance in the Silicones division.
  • Earnings before interest, taxes, depreciation and amortisation (EBITDA) amounted to NOK 632 million in the quarter, compared NOK 535 million in the third quarter 2023.
  • The result for the Silicones division clearly improved from a negative EBITDA contribution in the third quarter 2023.
  • "The macro-economic sentiment has been challenging in 2023, characterised by high inflation, interest rate hikes, slow recovery in China, and geopolitical uncertainties.